Amalgamated Bank Editas Medicine, Inc. Transaction History

Amalgamated Bank

  • $12.1 Billion
  • Q3 2024

A detailed history of Amalgamated Bank transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Amalgamated Bank holds 2,807 shares of EDIT stock, worth $6,764. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,807
Previous 2,807 -0.0%
Holding current value
$6,764
Previous $13,000 23.08%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024
SELL
$7.03 - $11.07 $34,805 - $54,807
-4,951 Reduced 63.82%
2,807 $21,000
Q4 2023

Feb 06, 2024
SELL
$6.25 - $11.11 $1,656 - $2,944
-265 Reduced 3.3%
7,758 $79,000
Q3 2023

Nov 08, 2023
BUY
$6.92 - $9.31 $8,483 - $11,414
1,226 Added 18.04%
8,023 $63,000
Q2 2023

Aug 11, 2023
SELL
$6.36 - $11.47 $1,984 - $3,578
-312 Reduced 4.39%
6,797 $55,000
Q1 2023

May 02, 2023
SELL
$7.03 - $11.53 $11,859 - $19,451
-1,687 Reduced 19.18%
7,109 $52,000
Q3 2022

Nov 09, 2022
BUY
$12.16 - $19.42 $1,045 - $1,670
86 Added 0.99%
8,796 $108,000
Q2 2022

Aug 15, 2022
SELL
$9.99 - $21.35 $24,395 - $52,136
-2,442 Reduced 21.9%
8,710 $103,000
Q1 2022

Jun 30, 2022
SELL
$14.08 - $27.63 $12,432 - $24,397
-883 Reduced 7.34%
11,152 $212,000
Q4 2021

Feb 15, 2022
SELL
$26.55 - $40.57 $3,451 - $5,274
-130 Reduced 1.07%
12,035 $320,000
Q3 2021

Oct 29, 2021
SELL
$39.27 - $72.94 $29,452 - $54,705
-750 Reduced 5.81%
12,165 $500,000
Q2 2021

Aug 16, 2021
BUY
$31.29 - $56.64 $106,730 - $193,199
3,411 Added 35.89%
12,915 $732,000
Q1 2021

May 13, 2021
SELL
$39.71 - $90.58 $12,349 - $28,170
-311 Reduced 3.17%
9,504 $399,000
Q4 2020

Feb 12, 2021
BUY
$27.07 - $84.35 $1,434 - $4,470
53 Added 0.54%
9,815 $688,000
Q3 2020

Oct 30, 2020
BUY
$28.06 - $37.16 $24,917 - $32,998
888 Added 10.01%
9,762 $274,000
Q2 2020

Aug 10, 2020
BUY
$18.5 - $34.34 $164,169 - $304,733
8,874 New
8,874 $262,000
Q1 2020

May 13, 2020
SELL
$14.88 - $32.78 $143,220 - $315,507
-9,625 Closed
0 $0
Q4 2019

Feb 13, 2020
BUY
$19.49 - $32.63 $14,227 - $23,819
730 Added 8.21%
9,625 $285,000
Q3 2019

Nov 13, 2019
SELL
$22.49 - $26.81 $1,326 - $1,581
-59 Reduced 0.66%
8,895 $202,000
Q2 2019

Aug 14, 2019
BUY
$20.48 - $27.76 $183,377 - $248,563
8,954 New
8,954 $222,000
Q3 2018

Nov 14, 2018
SELL
$27.65 - $38.39 $192,195 - $266,848
-6,951 Closed
0 $0
Q2 2018

Jul 18, 2018
BUY
$31.4 - $41.01 $218,261 - $285,060
6,951 New
6,951 $249,000

Others Institutions Holding EDIT

# of Institutions
247
Shares Held
57M
Call Options Held
410K
Put Options Held
394K
View Full List

About Editas Medicine, Inc.

EDIT Quotes by TradingView
  • Ticker EDIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,737,200
  • Market Cap $166M
  • Description
  • Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...
More about EDIT
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email